RadNet has added a $250M incremental term loan to support future acquisitions, organic expansion, health-system partnerships, and other corporate purposes, according to the company.
The financing was completed through Incremental Amendment No. 3 to RadNet’s existing first-lien credit and guaranty agreement. The new loan becomes part of the company’s existing term loan facility.
April 18, 2031, is the maturity date for the 2026 incremental term loan. That date matches the maturity of RadNet’s existing $958.7M term-loan balance under the same credit agreement.
Quarterly principal payments on the combined term loan will be approximately $3.1M, compared with approximately $2.4M before the amendment. RadNet also reduced the interest rate on the term loan by 0.25 percentage points to either Term SOFR plus 2.00% or the alternate base rate plus 1.00%, at its election.
RadNet said the amendment also lowers the interest rate on its existing $282M revolving credit facility by 0.25 percentage points. The company said the revolver is currently undrawn.
The completed loan is larger than the company’s earlier proposal. On June 3, RadNet announced that it was seeking a $200M incremental term loan for similar growth uses, including acquisitions, organic expansion, and health-system partnerships.
Proceeds from the $250M loan add to RadNet’s $455M cash balance as of March 31, 2026, according to the company. RadNet said its imaging-center markets include Arizona, California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas, and Virginia.
Company:RadNet
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
